Editorial Policies

SJEMed is owned by Waraqa Evidence Ltd, Riyadh, Saudi Arabia, and published by Discover STM Publishing Ltd. The Saudi Red Crescent Authority is an affiliated society; its members receive a 50% discount on the article processing charge. The society has no role in editorial decisions. SJEMed applies the editorial and ethical policies set out below, together with the journal's own requirements. The policies apply to authors, reviewers and editors. Where an SJEMed page gives more detail, it is linked in the section.

Best Practices in Research Reporting

Research must be reported according to the recognized standard for its study type. Authors should use the relevant reporting guideline from the EQUATOR Network. Case reports should follow the CARE guideline.

Animal Research

Research on animals must meet institutional and international animal-welfare standards. Authors must obtain the required ethics approval and permits and describe the oversight and methods in the manuscript.

Human Subjects Research

Research involving people must follow local regulations and international ethical standards, including the principles of the Declaration of Helsinki. Where ethics approval is required, it must be obtained before the research starts, and the approval or exemption details must be given in the manuscript. Authors must protect participants' privacy, record informed consent, and provide clinical-trial documents where relevant. A single case report does not usually need research ethics approval; for a case series, the need for approval depends on how it was designed and how the data were collected. See the Protection of Research Participants policy.

Competing Interests

Authors, reviewers and editors must declare financial and non-financial interests, including relationships that others might see as affecting the work. Reviewers and editors must step aside when an interest affects their impartiality. See the Conflict of Interest policy.

Disclosure of Funding Sources

Every manuscript must include a funding statement. Authors should name the funding body, the recipient, the grant number and the funder's role. If there was no external funding, the statement says so.

Content License

SJEMed articles are published under the Creative Commons Attribution 4.0 International license (CC BY 4.0). Authors keep the copyright, as set out in the Copyright Information and License Information pages.

Data, Materials and Software

Authors are encouraged to make materials and software available where this is ethically and legally possible. Authors must include a data availability statement in their manuscript, for example stating that no additional data are available, that data can be requested from the corresponding author, that the data are held in a named repository, or that patient data are not shared to protect confidentiality. Identifiable patient data must not be made public. See the Research Data Sharing Policies and the Publishing Ethics and Publication Malpractice Statement.

Authorship and Contributions

SJEMed follows the ICMJE authorship criteria. Every author must meet the criteria, approve the submitted and final versions, and be accountable for the work. Contributors who do not meet the criteria are named in the Acknowledgments. Authors are encouraged to provide ORCID iDs. Authorship disputes are for the authors and their institutions to resolve; the journal decides how a dispute affects publication.

Patient Confidentiality and Consent for Publication

Authors must remove identifying information that is not needed and protect patient confidentiality. Written consent for publication is required whenever a patient could be identified from the text, images or clinical details. Consent for publication is separate from consent for treatment or for research, and removing identifiers does not replace consent. See the Guide for Authors and the Protection of Research Participants policy.

Clinical-Trial Registration

Clinical trials must be registered in a public registry that meets international standards before the first participant is enrolled. The registry name and registration number must be given in the manuscript. If a trial was registered late, the authors must explain why, and the editors decide whether the manuscript can be considered. Registration is not required for case reports or observational studies.

Preprints

SJEMed accepts manuscripts that have been posted on a recognized preprint server; a preprint does not count as prior publication. Authors must declare the preprint at submission and give the server and the DOI or link. After publication, authors should update the preprint with a link to the published article. A preprint must not be described as peer reviewed.

Plagiarism, Originality and Redundant Publication

Submissions must be original. Plagiarism, copying without attribution and redundant publication are not accepted. SJEMed screens submissions with iThenticate and assesses any overlap in context, following COPE guidance; a similarity percentage alone does not prove plagiarism. See the Plagiarism Policy.

Artificial Intelligence in Manuscript Preparation

AI tools cannot be authors. Authors are fully responsible for the accuracy, integrity and originality of their work and must declare any use of generative AI, naming the tool and its purpose. AI may be used to help with language editing, translation or formatting, and this use must be declared in the Methods or Acknowledgments section. AI must not be used to create or alter data, references, clinical information or findings, and AI-generated images must never be presented as real patient images. See also the Publishing Ethics and Publication Malpractice Statement.

Artificial Intelligence, Reviewers and Editors

Reviewers and editors must not upload manuscripts, patient information, images or data to public AI tools that cannot keep them confidential. They remain responsible for their own assessments and decisions, and AI must not replace their judgment.

Image and Data Integrity

Images and data must show the original material accurately. Adjustments must not change what the image shows, and any processing must be stated. Undisclosed manipulation may be treated as misconduct. The editors may ask for the original, de-identified images.

Research and Publication Misconduct

SJEMed takes allegations of fabrication, falsification, plagiarism, image or data manipulation, redundant publication, authorship misconduct and other serious breaches seriously. The editors first ask the authors for an explanation. SJEMed does not carry out misconduct investigations itself; where an investigation is needed, the matter is referred to the authors' institution, following COPE guidance. See the Publishing Ethics and Publication Malpractice Statement.

Corrections, Retractions and Expressions of Concern

SJEMed publishes corrections, expressions of concern and retractions as set out in its Corrections, Retractions & Expressions of Concern policy.

Peer Review

Peer review follows SJEMed's Peer Review Policy and Editorial & Peer Review Process. Editorial decisions are based on scholarly merit.

Ethical Publishing Practices

SJEMed follows the Core Practices of the Committee on Publication Ethics (COPE) and the ICMJE Recommendations. In particular:

  • Editors judge manuscripts only on their scholarly merit, without regard to the authors' race, gender, religion, nationality, institution or ability to pay.
  • Editors, reviewers and editorial staff keep all submitted material confidential.
  • Editors and reviewers declare any conflict of interest and step aside from a manuscript where one exists.
  • Manuscripts submitted by an editor or editorial board member are handled by another editor. The author takes no part in the review or the decision, and the usual double-anonymized (double-blind) peer review applies.
  • Allegations of misconduct, before or after publication, are handled following the COPE flowcharts.
  • Authors may appeal an editorial decision by writing to the Editorial Office within 30 days, giving their reasons. The appeal is reviewed by an editor who was not involved in the original decision, and the outcome is final. Complaints about the journal's processes are handled in the same way and may be escalated to the publisher, Discover STM Publishing Ltd.
  • Errors in published articles are put right through a correction, an expression of concern or a retraction, as set out in SJEMed's Corrections, Retractions & Expressions of Concern policy.

Post-Publication Discussion

Readers who wish to comment on, question or add to an article published in SJEMed may submit a Letter to the Editor through the journal's online submission system, normally within six months of the article's publication. Letters are assessed by the editors and may be sent for peer review. Where a letter concerns a published article, the authors of that article are normally invited to reply, and the letter and the reply are published together. Any article processing charge for a letter is set out on the Article Processing Charges page. SJEMed does not publish open comments on article pages.

SJEMed does not carry out misconduct investigations itself; these are the responsibility of the authors' institution. If a letter or other report raises a possible error or ethical concern about a published article, the editors first ask the authors for an explanation. If the matter is not resolved, the editors refer it to the authors' institution and ask it to investigate. Readers with concerns about possible misconduct may also contact the authors' institution directly. SJEMed acts on the institution's findings, which may lead to a correction, an expression of concern or a retraction, as set out in its Corrections, Retractions & Expressions of Concern policy.

Advertising and Direct Marketing

SJEMed does not accept advertising on its website or in its articles.

Editorial decisions are never influenced by sponsorship or any other commercial interest. Any direct marketing by SJEMed or its publisher, such as emails inviting submissions or announcing new issues, is accurate, relevant to the recipient and not misleading. Promotional emails are sent only in line with the journal's Privacy Policy, and recipients can unsubscribe at any time.

Last reviewed: November 2026.